Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last hours
Enjoy this offer
* See conditions on site

Valuation: Sanofi

Capitalization 114B 130B 107B 96.34B 179B 11,084B 200B 1,238B 484B 5,026B 486B 476B 18,607B P/E ratio 2025 *
13.1x
P/E ratio 2026 * 12.7x
Enterprise value 120B 136B 112B 101B 188B 11,626B 210B 1,299B 508B 5,271B 509B 499B 19,516B EV / Sales 2025 *
2.65x
EV / Sales 2026 * 2.41x
Free-Float
87.31%
Yield 2025 *
4.32%
Yield 2026 * 4.57%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.25%
1 week+5.53%
Current month-2.24%
1 month+3.35%
3 months-9.96%
6 months+3.17%
Current year+0.01%
More quotes
1 week 90.93
Extreme 90.93
94.1
1 month 87
Extreme 87
98.36
Current year 86.14
Extreme 86.14
110.88
1 year 85.94
Extreme 85.94
110.88
3 years 76.45
Extreme 76.45
110.88
5 years 74.92
Extreme 74.92
110.88
10 years 62.5
Extreme 62.5
110.88
More quotes
Manager TitleAgeSince
Chief Executive Officer 57 2019-08-31
Director of Finance/CFO 63 2024-03-31
Chief Operating Officer 41 2023-09-30
Director TitleAgeSince
Director/Board Member 62 2013-05-02
Director/Board Member 71 2014-04-30
Director/Board Member 59 2019-04-29
More insiders
Name Weight AuM 1st Jan change
3.66% 139 M€ +14.15% -
More ETFs: Sanofi
Change 5d. change 1-year change 3-years change Capi.($)
+0.25%+5.53%+4.17%-8.36% 128B
-2.95%+1.31%-9.74%+142.58% 671B
-0.31%+4.66%+1.28%-13.45% 370B
-1.65%+2.46%+11.58%+20.39% 327B
+0.10%+5.49%-50.75%+19.95% 306B
-0.30%+3.18%+12.03%-17.86% 254B
+0.50%+4.95%-0.14%+8.14% 220B
+0.71%+4.69%-15.14%-0.02% 216B
-1.27%+4.78%-41.13%-17.71% 196B
-1.33%+3.45%-13.82%+9.63% 148B
Average -0.43%+3.31%-10.17%+14.33% 283.43B
Weighted average by Cap. -0.86%+2.97%-9.74%+34.41%
See all sector performances

Financials

2025 *2026 *
Net sales 45.22B 51.28B 42.32B 38.15B 70.91B 4,389B 79.33B 490B 192B 1,990B 192B 188B 7,368B 48.27B 54.73B 45.17B 40.71B 75.68B 4,684B 84.67B 523B 205B 2,124B 205B 201B 7,863B
Net income 8.83B 10.02B 8.27B 7.45B 13.85B 857B 15.49B 95.76B 37.45B 389B 37.57B 36.79B 1,439B 9.15B 10.37B 8.56B 7.72B 14.35B 888B 16.05B 99.2B 38.8B 403B 38.91B 38.11B 1,491B
Net Debt 5.58B 6.33B 5.22B 4.71B 8.75B 542B 9.79B 60.51B 23.66B 246B 23.73B 23.24B 909B 2.06B 2.34B 1.93B 1.74B 3.23B 200B 3.62B 22.36B 8.75B 90.77B 8.77B 8.59B 336B
More financial data * Estimated data
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (79.8%): prescription drugs in the areas of specialty medicine (63.2% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (36.8%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (20.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2024, the group had 52 production sites worldwide. In October 2024, the consumer healthcare products business (Opella) was classified as a discontinued operation. Net sales are distributed geographically as follows: France (4.4%), Europe (17.6%), the United States (48.7%), China (6.5%) and other (22.8%).
Employees
82,878
More about the company
Date Price Change Volume
25-05-21 93.75 +0.25% 1,612,621
25-05-20 93.52 +1.37% 1,893,715
25-05-19 92.26 +0.51% 1,476,252
25-05-16 91.79 +2.14% 2,310,105
25-05-15 89.87 +1.16% 1,656,539

Real-time Euronext Paris, May 21, 2025 at 11:39 am EDT

More quotes
Trading Rating
Investor Rating
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
93.75EUR
Average target price
117.70EUR
Spread / Average Target
+25.55%
Consensus

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
BENEFIT NOW